Kristen Williams Net Worth

The estimated Net Worth of Kristen Williams is at least 5.99 百万$ dollars as of 12 June 2024. Ms. Williams owns over 7,452 units of Pacira BioSciences Inc stock worth over 1,337,856$ and over the last 9 years she sold PCRX stock worth over 2,963,011$. In addition, she makes 1,692,720$ as Chief Administrative Officer、 Secretary at Pacira BioSciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Williams PCRX stock SEC Form 4 insiders trading

Kristen has made over 25 trades of the Pacira BioSciences Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently she sold 7,452 units of PCRX stock worth 211,488$ on 12 June 2024.

The largest trade she's ever made was exercising 83,577 units of Pacira BioSciences Inc stock on 15 September 2020 worth over 3,275,383$. On average, Kristen trades about 7,232 units every 89 days since 2015. As of 12 June 2024 she still owns at least 102,912 units of Pacira BioSciences Inc stock.

You can see the complete history of Ms. Williams stock trades at the bottom of the page.

Kristen Williams biography

Kristen Williams J.D. serves as Chief Administrative Officer, Secretary of the Company. She previously served as our Vice President, General Counsel from March 2013 to October 2014, as corporate counsel from December 2011 to March 2013, and as a legal consultant to our Company beginning in April 2011. Prior to joining Pacira, she was Vice President, Corporate Compliance and Assistant General Counsel for Bioenvision, Inc. from June 2004 until its merger with Genzyme Corporation in 2007. Prior to that, she practiced corporate law at Paul Hastings LLP in New York from September 1999 to June 2004, where her practice encompassed all aspects of public and private mergers and acquisitions, corporate finance, and securities law and compliance, with a core focus in the healthcare industry. Ms. Williams holds a B.S. in Business Administration from Bucknell University and a J.D. from the University of Denver, College of Law.

What is the salary of Kristen Williams?

As the Chief Administrative Officer、 Secretary of Pacira BioSciences Inc, the total compensation of Kristen Williams at Pacira BioSciences Inc is 1,692,720$. There are 3 executives at Pacira BioSciences Inc getting paid more, with David Stack having the highest compensation of 5,806,430$.

How old is Kristen Williams?

Kristen Williams is 46, she's been the Chief Administrative Officer、 Secretary of Pacira BioSciences Inc since 2014. There are 23 older and 1 younger executives at Pacira BioSciences Inc. The oldest executive at Pacira BioSciences Inc is Gary Pace, 72, who is the Independent Director.

What's Kristen Williams's mailing address?

Kristen's mailing address filed with the SEC is C/O PACIRA BIOSCIENCES, INC., 5401 WEST KENNEDY BOULEVARD, SUITE 890, TAMPA, FL, 33609.

Insiders trading at Pacira BioSciences Inc

Over the last 14 years, insiders at Pacira BioSciences Inc have traded over 321,391,130$ worth of Pacira BioSciences Inc stock and bought 2,075,444 units worth 15,133,188$ . The most active insiders traders include Advisors Llc Orbi Med Capit...、Carl L Gordon、Andreas Wicki. On average, Pacira BioSciences Inc executives and independent directors trade stock every 13 days with the average trade being worth of 491,036$. The most recent stock trade was executed by Marcelo Bigal on 16 August 2024, trading 1,512 units of PCRX stock currently worth 20,034$.

What does Pacira BioSciences Inc do?

pacira pharmaceuticals, inc. (nasdaq: pcrx) is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. the company's current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, exparel® (bupivacaine liposome injectable suspension), was commercially launched in the united states in april 2012. exparel and two other products have utilized the pacira proprietary product delivery technology depofoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time.

Complete history of Ms. Williams stock trades at Pacira BioSciences Inc

Pacira BioSciences Inc executives and stock owners

Pacira BioSciences Inc executives and other stock owners filed with the SEC include:

• David Stack,
  Chairman of the Board, Chief Executive Officer
• Max Reinhardt,
  President
• Dennis McLoughlin,
  Chief Commercial Officer
• Kristen Williams,
  Chief Administrative Officer, Secretary
• Roy Winston,
  Chief Clinical Officer
• David M. Stack,
  Chairman & CEO
• Charles Reinhart,
  Chief Financial Officer
• Dr. Roy Winston M.D.,
  Chief Medical Officer
• Christopher Christie,
  Director
• Max Reinhardt,
  Pres of Rest of World
• Dr. Jonathan Slonin M.D.,
  Chief Clinical Officer
• Kristen Williams,
  Chief Admin. Officer & Sec.
• Charles A. Reinhart III, CPA, M.B.A.,
  Chief Financial Officer
• Paul Hastings,
  Lead Independent Director
• Laura Brege,
  Independent Director
• John Longenecker,
  Independent Director
• Mark Kronenfeld,
  Independent Director
• Yvonne Greenstreet,
  Independent Director
• Mark Froimson,
  Independent Director
• Gary Pace,
  Independent Director
• Susan Mesco,
  IR Contact Officer
• Andreas Wicki,
  Independent Director
• Charles Laranjeira,
  Chief Technical Officer
• Kristen Williams J.D.,
  Chief Admin. Officer & Sec.
• Daryl Gaugler,
  Chief Operating Officer
• Robert J. Weiland,
  Sr. VP of Alliance Management
• Richard Kahr,
  VP of HR
• Charles Laranjeira,
  Chief Technical Officer
• Lauren Bullaro Riker,
  Principal Accounting Officer & VP of Fin.
• Dennis L Winger,
  Director
• Scott Braunstein,
  SVP, Strategy & Corp. Dev.
• Robert J. Weiland,
  Chief Commercial Officer
• Richard Scranton,
  Chief Scientific Officer
• James B Jones,
  SVP & Chief Medical Officer
• James S Scibetta,
  Chief Financial Officer
• Gary Patou,
  Director
• Taunia Markvicka,
  Vice President, Commercial
• Advisors Llc Orbi Med Capit...,
  
• Venture Partners Vi Lp Sand...,
  
• Bio Ventures Iv Qp Lpmpm Bi...,
  
• Bio Ventures Iv Qp Lp Scopa...,
  
• Carl L Gordon,
  Director
• Bio Ventures Iv Qp Lpmpm Bi...,
  
• Venture Partners Vi Lp Sand...,
  
• Luke Evnin,
  Director
• John Pratt,
  General Manager, San Diego
• Vaughn Mgadicke Ansbert Kai...,
  
• Bioventures Cayman Ltd Hbm,
  10% owner
• Fred A Middleton,
  Director
• Venture Partners Vi Lp Sand...,
  
• Venture Partners Vi Lp Sand...,
  
• Abraham Ceesay,
  Director
• Alethia Young,
  Director
• Marcelo Bigal,
  Director
• Michael J. Yang,
  Director
• Donald C. Manning,
  Chief Medical Officer
• Lauren Riker,
  Senior Vice President, Finance
• Anthony Molloy,
  Chief Lgl & Compliance Officer
• Daryl Gaugler,
  Chief Operating Officer
• Ronald J. Jr. Ellis,
  Chief Strategy Officer
• Jonathan Slonin,
  Chief Medical Officer
• Frank D. Lee,
  Chief Executive Officer